Adrenal hormonal imbalance in acute intermittent porphyria patients: Results of a case control study

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Pozo, Oscar J ^a   Marcos, Josep ^a,b   Fabregat, Andreu ^a   Ventura, Rosa ^a,b   Casals, Gregori ^c   Aguilera, Paula ^c   Segura, Jordi ^a,b   To Figueras, Jordi ^c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Acute intermittent porphyria; Metabolomics; Steroids; Urine

Indexed keywords

17 HYDROXYPREGNENOLONE; BIOLOGICAL MARKER; CORTICOESTERONE; CORTICOSTERONE; CORTISONE; CORTODOXONE; DEHYDROCORTICOSTERONE; DEOXYCORTICOSTERONE; HEME ARGINATE; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; PREGNENOLONE; PROGESTERONE; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MALE; STEROID URINE LEVEL; STEROIDOGENESIS; TANDEM MASS SPECTROMETRY;

ADRENAL GLANDS; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PORPHYRIA, ACUTE INTERMITTENT; STEROIDS; YOUNG ADULT;

EID: 84899978160     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-9-54     Document Type: Article

References (29)

1. Porphyrias. Puy H, Gouya L, Deybach JC, Lancet 2010 375 924 937 10.1016/S0140-6736(09)61925-5 20226990
2. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. Anderson KE, Sassa SS, Bishop DF, Desnick RJ, The metabolic basis of inherited disease New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, 8 2001
3. The incidence of inherited porphyrias in Europe. Elder G, Harper P, Badminton M, Sandberg S, Deybach JC, J Inherit Metab Dis 2013 36 5 849 857 10.1007/s10545-012-9544-4 23114748
4. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Kauppinen R, Mustajoki P, Medicine (Baltimore) 1992 71 1 13 1549056
5. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria. Hift RJ, Meissner PN, Medicine (Baltimore) 2005 84 48 60 10.1097/01.md.0000152454.56435. f3 15643299
6. Outside the box: genomic approach to acute porphyria. Thunell S, Physiol Res 2006 55 43 66
7. Acute porphyrias: pathogenesis of neurological manifestations. Meyer UA, Schuurmans MM, Lindberg RL, Semin Liver Dis 1998 18 43 52 10.1055/s-2007-1007139 9516677
8. Urinary excretion of porphyrins, porphobilinogen and δ- aminolaevulinic acid following an attack of acute intermittent porphyria. Marsden JT, Rees D, J Clin Pathol 2014 67 60 65 10.1136/jclinpath-2012-201367 23908454
9. Liver transplantation as a cure for acute intermittent porphyria. Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, Elias E, Lancet 2004 363 705 706 10.1016/S0140-6736(04)15646-8 15001330
10. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone releasing hormone. Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A, N Engl J Med 1984 311 643 645 10.1056/NEJM198409063111006 6433194
11. Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients. Deybach JC, Casamitjana R, Puy H, Herrero C, J Intern Med 2009 266 277 285 10.1111/j.1365-2796.2009.02118.x 19570056
12. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Casals G, Marcos J, Pozo OJ, Aguilera P, Herrero C, To-Figueras J, Clin Biochem 2013 46 9 819 824 10.1016/j.clinbiochem.2013.03.001 23499585
13. Circadian rhythms in acute intermittent porphyria-a pilot study. Larion S, Caballes FR, Hwang SI, Lee JG, Rossman WE, Parsons J, Steuerwald N, Li T, Maddukuri V, Groseclose G, Finkielstein CV, Bonkovsky HL, Eur J Clin Invest 2013 43 7 727 739 10.1111/eci.12102 23650938
14. European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Aarsand AK, Villanger JH, Støle E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S, Clin Chem 2011 57 11 1514 1523 10.1373/clinchem.2011.170357 21937752
15. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. To-Figueras J, Badenas C, Carrera C, Muñoz C, Mila M, Lecha M, Herrero C, J Inherit Metab Dis 2006 29 4 580 585 10.1007/s10545-006-0344-6 16817012
16. Acute intermittent porphyria and chronic renal failure. Marsden JT, Chowdhury P, Wang J, Deacon A, Dutt N, Peters TJ, Macdougall IC, Clin Nephrol 2008 69 5 339 346 10.5414/CNP69339 18538096
17. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 6 461 10.7326/0003-4819-130-6- 199903160-00002 10075613
18. Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Marcos J, Renau N, Casals G, Segura J, Ventura R, Pozo OJ, Anal Chim Acta 2014 812 92 104 24491769
19. The molecular biology, biochemistry and physiology of human steroidogenesis and its disorders. Miller WL, Auchus RJ, Endocr Rev 2011 32 1 81 151 10.1210/er.2010-0013 21051590
20. Steroid profile for urine: reference values. Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF, Wolthers BJ, Clin Chem 1989 35 2281 2284 2591044
21. Fischer DA, The Quest Diagnostic Manual, endocrinology. Test selection and interpretation. Quest Diagnostics Incorporated 2007 105
22. GC-MS steroid Profiling: Diagnosis of disorders affecting steroid synthesis and metabolism. Shackleton CHL, Marcos P, The Encyclopedia of Mass Spectrometry Amsterdam: Elsevier, Gross M, Caprioli R, 2006 789 813
23. Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria. Kappas A, Bradlow HL, Gillette PN, Gallagher TF, J Exp Med 1972 136 1043 1053 10.1084/jem.136.5.1043 4263649
24. Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria. Bradlow HL, Gillette PN, Gallagher TF, Kappas A, J Exp Med 1973 138 754 763 10.1084/jem.138.4.754 4270345
25. Urinary steroid hormone metabolites in patients with porphyria. Christakoudi S, Deacon AC, Peters TJ, Taylor NF, Endocrine Abstracts 2003 5 241
26. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle. Innala E, Bäckström T, Poromaa IS, Andersson C, Bixo M, Acta Obstet Gynecol Scand 2012 91 1445 1452 10.1111/j.1600-0412.2012.01536.x 22924787
27. 21-hydroxylase deficiency in the neonate-trends in steroid anabolism and catabolism during the first weeks of life. Christakoudi S, Cowan DA, Christakoudis G, Taylor NF, J Steroid Biochem Mol Biol 2013 138 334 347 23916492
28. The cortisol awakening response: more than a measure of HPA axis function. Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L, Neurosci Biobehav Rev 2010 35 97 103 10.1016/j.neubiorev.2009.12.011 20026350
29. Porphyrin induction: equivalent effects of 5alphaH and 5betaH steroids in chick embryo liver cells. Stephens JK, Fisher PV, Marks GS, Science 1977 197 4304 659 660 10.1126/science.877578 877578